Lin, Y.-C.; Chen, C.-H.; Lee, M.-S.; Lee, C.-F.; Hsiao, P.-W.; Huang, H.-P.; Pu, Y.-S.
Metabolomics-Based Liquid Biopsy for Predicting Clinically Significant Prostate Cancer. Cancers 2025, 17, 3815.
https://doi.org/10.3390/cancers17233815
AMA Style
Lin Y-C, Chen C-H, Lee M-S, Lee C-F, Hsiao P-W, Huang H-P, Pu Y-S.
Metabolomics-Based Liquid Biopsy for Predicting Clinically Significant Prostate Cancer. Cancers. 2025; 17(23):3815.
https://doi.org/10.3390/cancers17233815
Chicago/Turabian Style
Lin, Yuan-Chi, Chung-Hsin Chen, Ming-Shyue Lee, Cheng-Fan Lee, Pei-Wen Hsiao, Hsiang-Po Huang, and Yeong-Shiau Pu.
2025. "Metabolomics-Based Liquid Biopsy for Predicting Clinically Significant Prostate Cancer" Cancers 17, no. 23: 3815.
https://doi.org/10.3390/cancers17233815
APA Style
Lin, Y.-C., Chen, C.-H., Lee, M.-S., Lee, C.-F., Hsiao, P.-W., Huang, H.-P., & Pu, Y.-S.
(2025). Metabolomics-Based Liquid Biopsy for Predicting Clinically Significant Prostate Cancer. Cancers, 17(23), 3815.
https://doi.org/10.3390/cancers17233815